Neurology

Life After Diagnosis: Long-Term Monitoring and Wellness

At a Glance

Living with a benign schwannoma requires long-term MRI monitoring to check for tumor growth or recurrence. While recurrence and malignancy risks are very low, patients may need ongoing rehabilitation to manage lasting side effects like hearing loss, tinnitus, or facial weakness.

Living with a benign schwannoma often means shifting from a “treatment” mindset to a “survivorship” mindset. Because these tumors are slow-growing and rarely life-threatening, the journey involves long-term monitoring and managing any lasting effects on your nerves.

The Road Map for Monitoring

Whether you have chosen active surveillance or have already undergone treatment, MRI scans will be a regular part of your life. These scans allow your medical team to detect any changes early.

Standard Schedule: While every case is unique, a common schedule begins with a scan at 6 months post-diagnosis or post-treatment, followed by annual scans for several years ^[1]. If the area remains stable, your doctor may eventually move to scans every 2 or 3 years ^[1].
Active Surveillance: If you are “watching and waiting,” the goal is to document if the tumor is growing or if its shape is changing ^[2]^[1].
Post-Treatment: After surgery or radiosurgery, scans are used to check for tumor regrowth or, in the case of radiation, to confirm that the tumor has stopped growing (growth arrest) ^[3]^[4].

Understanding and Managing “Scanxiety”

It is completely normal to feel a surge of stress or emotional distress in the weeks and days leading up to an MRI—a phenomenon often called scanxiety ^[5]^[6].

To help manage this:

Physical Expectations: Knowing the logistics can help. Expect to lie still in a confined, tube-like space for 30 to 60 minutes. The machine will make loud knocking or buzzing noises, but you will be given earplugs or headphones ^[5].
Focus on the Present: Techniques like mindfulness or focusing on immediate, daily tasks can help pull your attention away from “what-if” scenarios ^[7]^[8].
Communication: Ask your doctor exactly how and when you will receive your results. Minimizing the “waiting period” between the scan and the explanation of the results is one of the best ways to reduce anxiety ^[5].
Education: Understanding your baseline results can help demystify the technical language used in radiology reports.

Managing Long-Term Side Effects

Sometimes, the tumor or the treatment itself leaves behind persistent symptoms. Modern rehabilitation can significantly improve your daily function.

Hearing and Tinnitus: If you experience hearing loss, options such as hearing aids or cochlear implants (CI) may be available ^[9]^[10]. Cochlear implants have also been shown to be effective in reducing the burden of persistent tinnitus (ringing in the ears) ^[11]^[12].
Facial Nerve Support: If you experience facial weakness or numbness, specialized physical therapy (facial retraining) can help improve muscle tone and symmetry.
Balance Training: Vestibular rehabilitation—a specific type of physical therapy—can help your brain “re-calibrate” and improve your balance if your vestibular nerve was affected ^[13].

Recurrence and Malignant Transformation

Two of the most common fears are that the tumor will return or turn into cancer.

Recurrence Risk: For patients who have a single tumor completely removed (gross total resection), the risk of it returning is very low—approximately 3% ^[14]. The risk is higher if the tumor could only be partially removed to protect a nerve ^[14]^[15].
Malignant Transformation: The chance of a benign schwannoma becoming a Malignant Peripheral Nerve Sheath Tumor (MPNST) is exceptionally rare ^[16]. However, this risk is slightly higher for patients with a genetic schwannomatosis syndrome, particularly if their tumors were previously treated with radiation ^[17]. High-risk red flags that would prompt your doctor to investigate this include rapid new pain, sudden muscle weakness, or a tumor that grows very quickly on an MRI ^[18]^[19].

Your medical team uses long-term monitoring as a safety net, ensuring that you can live your life with the confidence that any changes will be caught and addressed promptly.

Common questions in this guide

How often will I need MRI scans for a benign schwannoma?

Typically, you will have an MRI 6 months after your diagnosis or treatment, followed by annual scans for several years. If the tumor or surgical site remains stable, your doctor may eventually spread the scans out to every two or three years.

What is the risk of a benign schwannoma returning after surgery?

If the tumor was completely removed during surgery, the risk of it returning is very low, at approximately 3 percent. The risk is slightly higher if only part of the tumor could be removed to protect the surrounding nerves.

Can a benign schwannoma turn into cancer?

It is exceptionally rare for a benign schwannoma to transform into a cancer. The risk is slightly higher if you have a genetic schwannomatosis syndrome or if your tumor was previously treated with radiation.

What options are available for hearing loss and tinnitus caused by my schwannoma?

Patients with persistent hearing loss may benefit from hearing aids or cochlear implants. Cochlear implants have also been shown to be effective in reducing the burden of persistent tinnitus, or ringing in the ears.

How can I manage anxiety before my MRI scans?

Managing 'scanxiety' can be done by learning what to expect physically during the scan, practicing mindfulness techniques, and asking your doctor exactly how and when you will receive your results to minimize the stressful waiting period.

Curated prompts to bring to your next appointment.

1.Based on my specific surgery or radiation treatment, what is the 'new baseline' on my MRI that I should expect to see in future reports?
2.What is the exact schedule for my follow-up scans over the next five years?
3.If my tumor was not completely removed (subtotal resection), what signs of regrowth should we be looking for on my scans?
4.Can you refer me to a specialist for auditory or facial rehabilitation to help manage my persistent symptoms?
5.Is there a way for me to receive my scan results faster to help manage my anxiety during the waiting period?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (19)

1
Upfront radiation for small, nongrowing vestibular schwannomas: a call for caution.
Andresen NS, Macielak RJ, Schoo DP, et al.
Neurosurgical review 2025; (49(1)):18 doi:10.1007/s10143-025-03936-w.
PMID: 41269367
2
Tumor shape as a prognostic factor for the growth of intracanalicular vestibular schwannoma: a long-term observational study.
Lee SA, Lee JH, Hong HS, Lee JD
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2024; (281(8)):4063-4068 doi:10.1007/s00405-024-08540-0.
PMID: 38498190
3
Predictors of Growth of Vestibular Schwannoma After Gamma Knife Treatment: A Systematic Review.
Yang C, Alvarado D, Ravindran PK, et al.
Cancers 2025; (17(12)) doi:10.3390/cancers17121993.
PMID: 40563642
4
The Effectiveness of Diffusion Tensor Imaging in Determining Radiological Response after Radiosurgery in Patients with Vestibular Schwannoma.
Cesme DH, Alkan A, Sari L, et al.
Current medical imaging 2021; (17(5)):602-607 doi:10.2174/1573405617666210127160848.
PMID: 33504315
5
Scanxiety and quality of life around follow-up imaging in patients with unruptured intracranial aneurysms: a prospective cohort study.
Kamphuis MJ, van der Kamp LT, van Eijk RPA, et al.
European radiology 2024; (34(9)):6018-6025 doi:10.1007/s00330-024-10602-0.
PMID: 38311702
6
Prevalence, severity, and modifiable predictors of scanxiety in patients undergoing routine oncologic imaging: a prospective longitudinal study.
Shah MS, Memon JA, Malik U, et al.
Clinical imaging 2025; (128()):110634 doi:10.1016/j.clinimag.2025.110634.
PMID: 41077027
7
Coping With 'Scanxiety': Within-Person Processes in Lung Cancer.
Dunsmore VJ, Neupert SD
Psychological reports 2025; (128(2)):702-722 doi:10.1177/00332941231164336.
PMID: 36964680
8
The effect of virtual reality and music on pain, anxiety, and pain-related anxiety in burn patient care.
Görücü R, Özteki̇n SD, Fi̇li̇nte G
Burns : journal of the International Society for Burn Injuries 2025; (51(7)):107580 doi:10.1016/j.burns.2025.107580.
PMID: 40555099
9
Cochlear implantation in vestibular schwannoma: A game changer? A narrative review.
Lassaletta L, Calvino M, Sánchez-Cuadrado I, et al.
Brazilian journal of otorhinolaryngology 2025; (91(3)):101563 doi:10.1016/j.bjorl.2025.101563.
PMID: 39914046
10
Hearing Rehabilitation with Cochlear Implants after CyberKnife Radiosurgery of Vestibular Schwannoma: A Report Based on Four Clinical Cases.
Häußler SM, Szczepek AJ, Gräbel S, et al.
Brain sciences 2021; (11(12)) doi:10.3390/brainsci11121646.
PMID: 34942948
11
Cochlear Implantation for Patients with a Vestibular Schwannoma: Effect on Tinnitus Handicap.
West N, Bunne M, Sass H, Cayé-Thomasen P
The journal of international advanced otology 2022; (18(5)):382-387 doi:10.5152/iao.2022.21541.
PMID: 36063093
12
Cochlear implantation improves hearing and vertigo in patients after removal of vestibular schwannoma.
Roemer A, Lenarz T, Lesinski-Schiedat A
The international tinnitus journal 2017; (21(1)):2-6 doi:10.5935/0946-5448.20170002.
PMID: 28723594
13
Communicating Hydrocephalus After Radiotherapy for a Vestibular Schwannoma.
Set HHM, Sann KN, Shanmugasundaram R
Cureus 2025; (17(9)):e91903 doi:10.7759/cureus.91903.
PMID: 40933901
14
The Long-term Outcome After Resection of Intraspinal Nerve Sheath Tumors: Report of 131 Consecutive Cases.
Halvorsen CM, Rønning P, Hald J, et al.
Neurosurgery 2015; (77(4)):585-92; discussion 592-3 doi:10.1227/NEU.0000000000000890.
PMID: 26191976
15
Management of peripheral nerve sheath tumors: 17 years of experience at Toronto Western Hospital.
Guha D, Davidson B, Nadi M, et al.
Journal of neurosurgery 2018; (128(4)):1226-1234.
PMID: 28686119
16
Malignant Transformation of Schwannoma to S-100 Negative Epithelioid Malignant Peripheral Nerve Sheath Tumor: A Case Report.
Shirai Y, Matsuoka M, Okawa H, et al.
International journal of surgical pathology 2026; (34(1)):187-193 doi:10.1177/10668969251357026.
PMID: 40653799
17
Spontaneous Transformation of Vestibular Schwannoma into Malignant Peripheral Nerve Sheath Tumor.
Belyaev A, Usachev D, Shimansky V, et al.
Asian journal of neurosurgery 2018; (13(3)):810-813 doi:10.4103/ajns.AJNS_251_16.
PMID: 30283553
18
Malignant Cerebellopontine Angle Peripheral Nerve Sheath Tumor with Divergent Mesenchymal (Cartilaginous) Differentiation Presenting with Catastrophic Hemorrhage: Case Report and Review.
Lai C, Bajin D, Chen JM, et al.
The journal of international advanced otology 2023; (19(2)):155-158 doi:10.5152/iao.2023.22799.
PMID: 36975088
19
High-Grade Sarcoma Arising within a Previously Irradiated Vestibular Schwannoma: A Case Report and Literature Review.
Boucher AB, Mendoza P, Neill SG, et al.
World neurosurgery 2020; (144()):99-105 doi:10.1016/j.wneu.2020.08.170.
PMID: 32889192

This page is for educational purposes regarding benign schwannoma survivorship and monitoring. It does not replace professional medical advice or personalized care plans from your healthcare team.

Get notified when new evidence is published on Benign schwannoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents